Elevate Capital Advisors’s Clorox CLX Stock Holding History

Elevate Capital Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,408	Closed	-$796K	–	69
2025 Q1	$796K	Buy	5,408 +273	+5%	+$41.7K	0.74%	49
2024 Q4	$834K	Buy	+5,135	New	+$840K	0.73%	52

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Elevate Capital Advisors's CLX Position: Q2 2025 in Review

Elevate Capital Advisors sold out of Clorox (CLX) in Q2 2025, closing a stake of 5,408 shares — an estimated $796K sold.

Elevate Capital Advisors first reported a position in CLX in Q4 2024 and held it in 2 quarters. The position peaked at $834K in Q4 2024. 1,125 funds tracked by Wall St. Rank hold CLX as of Q2 2025.

Elevate Capital Advisors reported no remaining Clorox position as of Q2 2025 after selling out during the quarter.
Elevate Capital Advisors sold 5,408 Clorox shares in Q2 2025, an estimated $796K.
Elevate Capital Advisors first reported a position in Clorox in Q4 2024 and held it in 2 quarters.
Elevate Capital Advisors's Clorox position peaked at $834K in Q4 2024.
1,125 funds tracked by Wall St. Rank held Clorox as of Q2 2025.

Based on Elevate Capital Advisors's 13F filing for Q2 2025, filed 22 Jul 2025.